CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vifor Pharma (Switzerland), Switzerland, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
58%
Total
Publications
1K
Total Open
Publications
580
Total
Citations
30K
Open Access
Percentage
58%
Total
Publications
1K
Total Open
Publications
580
Total
Citations
30K
Breakdown
Publisher Open
25%
Both
25%
Other Platform Open
8%
Closed
42%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 27%
138
Hybrid 43%
216
No Guarantees 30%
150
Other Platform Open
Domain 70%
233
Institution 40%
133
Other Internet 22%
74
Public 9%
31
Preprint 9%
29
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 233 |
Europe PMC | Domain | 108 |
University of Groningen / Centre for Information Technology - University of Groningen research database | Institution | 33 |
Paul Scherrer Institute - DORA PSI | Other Internet | 33 |
Semantic Scholar | Public | 30 |
University College London - UCL Discovery | Institution | 26 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 18 |
arXiv | Preprint | 18 |
St George's University of London - St George's Online Research Archive | Institution | 17 |
University of Zurich - Zurich Open Repository and Archive | Institution | 16 |